Eli Lilly and Co (LLY)
747.82
-2.10
(-0.28%)
USD |
NYSE |
Nov 22, 16:00
747.05
-0.77
(-0.10%)
After-Hours: 20:00
Eli Lilly Cash from Operations (Quarterly): 3.712B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.712B |
| June 30, 2024 | 1.466B |
| March 31, 2024 | 1.166B |
| December 31, 2023 | -311.90M |
| September 30, 2023 | 2.190B |
| June 30, 2023 | 631.90M |
| March 31, 2023 | 1.731B |
| December 31, 2022 | 1.663B |
| September 30, 2022 | 2.217B |
| June 30, 2022 | 1.183B |
| March 31, 2022 | 2.523B |
| December 31, 2021 | 2.262B |
| September 30, 2021 | 1.631B |
| June 30, 2021 | 1.776B |
| March 31, 2021 | 1.697B |
| December 31, 2020 | 1.815B |
| September 30, 2020 | 1.807B |
| June 30, 2020 | 2.495B |
| March 31, 2020 | 382.40M |
| December 31, 2019 | 1.964B |
| September 30, 2019 | 1.510B |
| June 30, 2019 | 1.052B |
| March 31, 2019 | 311.30M |
| December 31, 2018 | 1.449B |
| September 30, 2018 | 2.122B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.518B |
| March 31, 2018 | 436.50M |
| December 31, 2017 | 1.744B |
| September 30, 2017 | 1.881B |
| June 30, 2017 | 1.651B |
| March 31, 2017 | 339.90M |
| December 31, 2016 | 2.006B |
| September 30, 2016 | 1.662B |
| June 30, 2016 | 1.402B |
| March 31, 2016 | -219.10M |
| December 31, 2015 | 996.10M |
| September 30, 2015 | 1.105B |
| June 30, 2015 | 948.60M |
| March 31, 2015 | -84.80M |
| December 31, 2014 | 1.441B |
| September 30, 2014 | 1.691B |
| June 30, 2014 | 1.054B |
| March 31, 2014 | 272.30M |
| December 31, 2013 | 1.727B |
| September 30, 2013 | 1.992B |
| June 30, 2013 | 1.637B |
| March 31, 2013 | 379.40M |
| December 31, 2012 | 1.602B |
| September 30, 2012 | 1.544B |
| June 30, 2012 | 1.306B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-311.90M
Minimum
Dec 2023
3.712B
Maximum
Sep 2024
1.700B
Average
1.753B
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 3.571B |
| Biogen Inc | 935.60M |
| Johnson & Johnson | 7.993B |
| Viking Therapeutics Inc | -21.96M |
| Moderna Inc | -1.566B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.005B |
| Cash from Financing (Quarterly) | 211.30M |
| Free Cash Flow | -2.275B |
| Free Cash Flow Per Share (Quarterly) | -0.5071 |
| Free Cash Flow to Equity (Quarterly) | -2.687B |
| Free Cash Flow to Firm (Quarterly) | -370.39M |
| Free Cash Flow Yield | -0.34% |